Address : Shanghai, China
Phone Number : +86 21 6057 8000
Industries : Biotechnology, Pharmaceuticals
Website : i-mabbiopharma.com
Company Description
I-Mab (Nasdaq: IMAB) is a global biotechnology company focused on bringing highly differentiated medicines to patients around the world through the discovery, development, and commercialization of novel immunotherapies and biologics for oncology. I-Mab's innovative pipeline is driven by internal R&D's Fast-to-Proof-of-Concept, Fast-to-Market development strategies, and through global partnerships.
Specialities
- Biopharmaceutical
- Immunooncology
- Oncology
- Pharmaceutical
- Biotechnology
- Biotechnology: Pharmaceutical Preparations
- Hospital & Health Care
- Health, Wellness & Fitness
- Antibody
- Immunoinflammation
- Biologics
- Drug Development
- Pharmaceuticals
- Health Care
- Medical
Financial
Employees Total : 170
Revenue (Yearly) : 230M
Total Funding : 915.8M
Latest Funding : 418M
Public Company : Yes
Trade Symbol : IMAB
Trade Exchange : Nasdaq
Market Cap : 230M
Miscellaneous
Founded in : 2016
Twitter : IMabBiopharma
Linkedin : i-mab
Email Providers : Outlook
Advertising Networks : Baidu Ads
Tech : Mobile Friendly
Frameworks and Programming Languages : ASP.NET
CMS : WordPress.org
Load Balancers : Microsoft-IIS
Last Updated : 2023-12-04
Employees
- Zhan Wang ( Global Director of Pharmacometrics )
- Dan Chen ( CMC Associate QA Director )
- Linqiang Han ( Manager, Clinical Supply Chain )
- Meifang Zhang ( Strategic and planning director )
- Dorothy Chang ( Associate Director )
- Aihua Wang ( **** ********* ******** ******** )
- Daniel Peng ( Associate IT Infrastructure Director )
- Lan Kang ( Non Executive Board Member )
You Might Be Interested With:
 | NanoBiz LLC Branchburg, New Jersey, United States Management Consulting |
 | Smoove Xperience Singapore Information Technology & Services |
 | Media Group Pte Ltd Singapore Publishing |
 | FNCB Bank Dunmore, Pennsylvania, United States Banking |
 | Parent Talk With Kary Nashville, Tennessee, United States |
 | Athalos |